<bill session="114" type="h" number="1455" updated="2015-05-09T06:33:23-04:00">
  <state datetime="2015-03-18">REFERRED</state>
  <status>
    <introduced datetime="2015-03-18"/>
  </status>
  <introduced datetime="2015-03-18"/>
  <titles>
    <title type="short" as="introduced">Speeding Access to Already Approved Pharmaceuticals Act of 2015</title>
    <title type="official" as="introduced">To require the Food and Drug Administration to expedite review of pharmaceuticals that are approved for marketing in the European Union.</title>
  </titles>
  <sponsor id="412461"/>
  <cosponsors>
    <cosponsor id="400352" joined="2015-03-18"/>
  </cosponsors>
  <actions>
    <action datetime="2015-03-18" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2015-03-20">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary>3/18/2015--Introduced.
Speeding Access to Already Approved Pharmaceuticals Act of 2015

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to facilitate the development and expedite the review of a new drug, biological product, or device that has been approved in the European Union.</summary>
</bill>
